Founder of an innovation-driven pharmaceutical startup focused on merging active ingredients and transforming traditional dosage forms into modern, patient-friendly solutions. Backed by 8 filed patents (target: 20) and a validated B2B go-to-market strategy targeting GCC and MENA regions. Startup Overview Current :Pre-launch pharmaceutical company Mission: To simplify and modernize drug delivery for better patient outcomes and reduced healthcare costs. Product Innovation: Combines APIs and shifts traditional dosage forms into FDA-recognized innovative forms (e.g., oral disintegrating films.) Patents: 8 filed, 12 in progress (target: 20 total) Target Products: 40 pharmaceutical products over 5 years Model: B2B – Licensing & Distribution Go-to-Market: Within 12 months Export Focus: GCC + Egypt